Recursion Pharmaceuticals (RXRX) PT Lowered to $5.30 at Morgan Stanley
Morgan Stanley analyst Sean Laaman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
